marimastat has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, M; Chang, S; Devriendt, D; Kunwar, S; Lamborn, KR; Larson, DA; McDermott, MW; Nicholas, KM; Prados, M; Smith, V; Sneed, PK; Wara, WM | 1 |
| Baillet, M; Barker, K; Berrington, A; Bleiberg, H; Brown, PD; Daniel, F; Johnson, PW; Lynch, KP; Mansi, JL; Millar, AW; Neoptolemos, JP; Primrose, JN; Seymour, M; Van Belle, S | 1 |
2 trial(s) available for marimastat and Recrudescence
| Article | Year |
|---|---|
Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma.
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Radiation; Enzyme Inhibitors; Female; Follow-Up Studies; Glioma; Humans; Hydroxamic Acids; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiosurgery; Recurrence; Time Factors; Treatment Outcome | 2002 |
Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Muscle, Skeletal; Pilot Projects; Recurrence | 1999 |